Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Si-Shu Zhao"'
Autor:
Run Zhang, Xiaoyan Qu, Jianyong Li, Yuanyuan Jin, Yu-Jie Wu, Wenmin Han, Si-Shu Zhao, Lijuan Chen, Qinglin Shi, Chao Wu
Publikováno v:
Leukemia & Lymphoma. 62:709-715
The aim of our study was to determine the impact of CD200 expression in newly diagnosed myltiple myeloma (MM) patients. CD200+ patients had significantly shorter median overall survival time (OS) t...
Autor:
Yuanyuan Jin, Xiaoyan Qu, Si-Shu Zhao, Wu Yujie, Yan Gu, Qinglin Shi, Jianyong Li, Jie Ding, Chen Lijuan
Publikováno v:
Leukemia & Lymphoma. 61:1869-1876
The T lymphocyte system plays an active role in tumor immunosurveillance in multiple myeloma (MM), and abnormal T lymphocyte populations are often observed in patients with MM. In the current study, we evaluated the prognostic impact of abnormal T ly
Autor:
Guangsheng He, Qiqiang Long, Hui Yang, Jianyong Li, Ji Xu, Lei Cao, Si-Shu Zhao, Yan Wang, Rong Wang
Publikováno v:
Translational Cancer Research
Acute basophilic leukemia (ABL), as a rare form of acute myeloid leukaemia (AML) accounts for
Autor:
Jianyong Li, Lijuan Chen, Xiaoyan Qu, Wenmin Han, Yuanyuan Jin, Yu-Jie Wu, Min Xu, Si-Shu Zhao, Qinglin Shi, Run Zhang
Publikováno v:
Hematology (Amsterdam, Netherlands). 26(1)
OBJECTIVES Multiple myeloma (MM) involves a clinically and biologically heterogeneous malignancy of plasma cells. It is difficult to predict the prognosis of MM. The presence of circulating clonal plasma cells (CPC) has been associated with a worse p
Autor:
Jie, Ding, Yan, Gu, Si-Shu, Zhao, Yu-Jie, Wu, Qing-Lin, Shi, Xiao-Yan, Qu, Jian-Yong, Li, Li-Juan, Chen
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 27(6)
To investigate the expression level of T lymphocyte subsets in elderly patients with newly diagnosed multiple myeloma (NDMM), and to evaluated the prognostic value of T lymphocytic abnormalities in elderly NDMM patients.Pretreated peripheral blood of
Publikováno v:
OncoTargets and therapy
Background Mixed lineage leukemia (MLL) fusion protein alone exhibits poor histone lysine methyltransferase (HKMT) activity in catalyzing histone H3 Lys4 trimethylation (H3K4me3) in MLL-rearranged acute leukemia. Methods To explore the HKMT effect of
Autor:
Kou-Rong Miao, Xiao-Tong Li, Yu-Jie Wu, Wei Xu, Li Wang, Yi-Xin Zou, Yi Xia, Si-Shu Zhao, Jianyong Li, Hua-Yuan Zhu
Publikováno v:
Hematological oncologyREFERENCES. 37(4)
Ibrutinib, a first-generation Bruton's tyrosine kinase (BTK) inhibitor, could improve immunity of relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients. Whether zanubrutinib, a second-generation BTK i
Publikováno v:
Leukemia & Lymphoma. 2020Supplement, Vol. 61, p1-274. 274p.
Autor:
Wu, Yu-Jie (AUTHOR), Li, Li-xia (AUTHOR), Liu, Lu (AUTHOR), Zhao, Si-shu (AUTHOR), Qiu, Hai-rong (AUTHOR), Wang, Hui (AUTHOR)
Publikováno v:
OncoTargets & Therapy. Jan2020, Vol. 13, p381-387. 7p.